期刊文献+

Fabrication and Properties of Multilayer Chitosan Membrane Loaded with Tinidazole 被引量:1

Fabrication and Properties of Multilayer Chitosan Membrane Loaded with Tinidazole
下载PDF
导出
摘要 With the aim of providing effective periodontal disease therapeutic method, multilayer membranes which were loaded with drug for guided tissue regeneration were prepared using an immerseprecipitation phase inversion technique. Single layer, bi-layer and tri-layer membranes were fabricated with chitosan used as cartier and tinidazole as medicine model which was loaded on the membrane. The influence of layer on structure and properties of membrane were studied by SEM, UV spectrophotometer and mechanical test. Drug release properties of three types of layer membranes were also investigated. The results showed that release rate could be slown down in both bi-layer and tri-layer membranes (to 11 days and 14 days respectively) and tri-layer membrane lasted the longest. After a process of rapid release, the concentration of tinidazole which was released by the membrane was maintained at an efficient dosage level. Compared with single layer and bi- layer membranes, we found tri-layer membrane could play a role in controlling low-rate drug release especially at the early stage of release, and keep an efficient dosage at affected part for a long period of time. The loss of drug which loaded on membrane decreased from 84.6% for single layer to 13.04% for tri-layer. The mechanical strength of three types of membrane were detected and showed that it could meet the requiremens of clinical practice. The membranes especially with tri-layer could be more valuable in application. With the aim of providing effective periodontal disease therapeutic method, multilayer membranes which were loaded with drug for guided tissue regeneration were prepared using an immerseprecipitation phase inversion technique. Single layer, bi-layer and tri-layer membranes were fabricated with chitosan used as cartier and tinidazole as medicine model which was loaded on the membrane. The influence of layer on structure and properties of membrane were studied by SEM, UV spectrophotometer and mechanical test. Drug release properties of three types of layer membranes were also investigated. The results showed that release rate could be slown down in both bi-layer and tri-layer membranes (to 11 days and 14 days respectively) and tri-layer membrane lasted the longest. After a process of rapid release, the concentration of tinidazole which was released by the membrane was maintained at an efficient dosage level. Compared with single layer and bi- layer membranes, we found tri-layer membrane could play a role in controlling low-rate drug release especially at the early stage of release, and keep an efficient dosage at affected part for a long period of time. The loss of drug which loaded on membrane decreased from 84.6% for single layer to 13.04% for tri-layer. The mechanical strength of three types of membrane were detected and showed that it could meet the requiremens of clinical practice. The membranes especially with tri-layer could be more valuable in application.
作者 洪华 刘昌胜
出处 《Journal of Wuhan University of Technology(Materials Science)》 SCIE EI CAS 2007年第1期102-107,共6页 武汉理工大学学报(材料科学英文版)
基金 Supported by the State Outstanding Young Talents Foundation ( No.20425621)
关键词 CHITOSAN MEMBRANE MULTILAYER drug loss release rate chitosan membrane multilayer drug loss release rate
  • 相关文献

参考文献12

  • 1Xiu Wencui.The Research of Periodontal Tissue Stress Distribution under the Orthoraedic Force and the Control of.
  • 2Brook I;Frazier EH;Thompson DH.Aerobic and Anaerobic Microbiology of Periapical Abscess,1991(01).
  • 3S V Emshanova;A P Zuev.Composition and Technology of Tinidazole Core Tablets,2004(11).
  • 4V I Levina;L A Trukhacheva.Investigation of the No-donor Activity of the Antimicrobial Drug Tinidazole[J],2004(01).
  • 5Park JS;Choi SH;Moon IS.Eight Week Histological Analysis on the Effect of Chitosan on Surgically Created Onewall Intrabony Defects in Beagle Dogs,2003.
  • 6Madihally Sundararajan V;Matthew Howard W T.Porous Chitosan Scaffolds for Tissue Engineering[J],1999(12).
  • 7Senel S;Kremer M J;Kas S.Enhancing Effect of Chitosan on Peptide Drug Delivery across Buccal Mucosa[J],2000.
  • 8Singla AK;Chawla M Chitosan.Some Pharmaceutical and Biological Aspects-An Update,2001.
  • 9Nsereko S;Amiji M.Localized Delivery of Paclitaxel in Solid Tumors from Biodegradable Chitin Microparticle Formulations[J],2002.
  • 10VandeVord PJ;Matthew HW;DeSilva SP.Evaluation of the Biocompatibility of a Chitosan Scaffold in Mice,2002.

同被引文献19

  • 1孙利华,黄泰康,吴春福.对我国药品管理使命的思考[J].中国药房,2007,18(13):971-974. 被引量:15
  • 2Cook D. Ventialator associated pneumonia: perspectives on the burden of illness [J]. Intensive Care Meal, 2007, 26(11): 31-37.
  • 3Ellis BL, Hirsch ML, Porter SN, et al. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs [J]. University of Texas Southwestern Medical Center, 2011, 2(11): 1038-1048.
  • 4Davit BM, Nwakama PE, Buehler GJ, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration [J]. Center for Drug Evaluation and Research, 2009, 43(10):1583-1597.
  • 5Ponto T, Ismail NI, Marmaya NH, et al. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department [J]. Department of Clinical Pharmacy, 2010, 32(6): 427-443.
  • 6Vollmcr WM, Xu M, Feldstein A, et al. Comparison of pharmacy-based measures of medication adherence[J]. BMC Health Serv Rcs, 2012, 12(1):155.
  • 7Jenkins A, Eckel SF.Analyzing methods for improved management ofworkflow in an outpatient pharmacy setting [J]. Am J Health Syst Pharm, 2012, 69(11):966-971.
  • 8Beatty S J, Beale D J, Rodis JL, et al. Current trends in outpatient pharmacy services and billing [J]. College of Pharmacy, 2012, 52(2): 154-160.
  • 9Vitezic D, Madjarevic T, Gantumur M, et al. Outpatient drugs usage in Croatia during the 8-year period: influences of pricing policy changes[J]. Int J Clin Pharmacol Ther, 2012.
  • 10Phillips BB, Williams KC. Implementation of a pharmacy residency in a Veterans Affairs commtmity-based outpatient clinic [J]. Am J Health Syst Pharm, 2012, 69(10):880-884.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部